Hemolysis may occur during infusion of an ABO-incompatible HSC component if the
recipient has isoagglutinins directed against donor red blood cells, or later as a result of the …

BACKGROUND: Hemolysis as a result of donor‐recipient minor ABO mismatching is a
complication of allogeneic peripheral blood progenitor cell (PBPC) transplantation (PBPCT) …

BACKGROUND: Most studies indicate that ABO incompatibility has no effect on the clinical
outcome after allogeneic peripheral blood progenitor cell (PBPC) transplantation (allo …

We investigated the changes in isoagglutinin titres in 62 patients who underwent ABO‐
incompatible allogeneic stem cell transplantation. After major [and/or (±) minor] ABO …

Few studies have addressed the incidence of graft-versus-host disease (GVHD) or survival
after ABO-incompatible allogeneic peripheral blood stem cell transplantation (PBSCT). We …

Hematopoietic progenitor cell (HPC) transplantation has long been established as the
optimal treatment for many hematologic malignancies. In the setting of allogenic HLA …

BACKGROUND: Bone marrow transplantation with minor ABO incompatibility may be
followed by moderate delayed hemolysis of the recipient's red cells by donor‐derived ABO …

BACKGROUND: After allogeneic peripheral blood progenitor cell (PBPC) transplantation, a
patient developed a severe hemolytic transfusion reaction due to passenger lymphocyte …

In addition to alloimmune and autoimmune cell lysis, a third category of immune destruction
of blood cells should be recognized. This additional immunologic response occurs when …

ABO incompatibility is not considered a contraindication for allogeneic haematopoietic stem
cell transplantation (HSCT) despite its association with several immunohaematological …